It is worthy of noting that we recently identified a compound, named MIBE, that exhibits the peculiar feature of acting as an antagonist ligand of both GPER and ER in breast cancer cells (Lappano et al., 2012a). The gene discussed is ESR1; the disease is breast carcinoma.